agilon health, inc.

agilon health, inc. (AGL) Stock Analysis

$92.540

-1.610 (-1.74%)At close

Loading chart…
High
94.730
Open
93.930
VWAP
92.75
Vol
135.63K
Mkt Cap
2.71B
Low
90.990
Amount
12.58M
EV/EBITDA, TTM
13.80

agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital.

AI analysis of agilon health, inc. (AGL)

hold

Agilon Health Inc is currently a hold. The stock is priced at $92.54, with a recent RSI of 42.18 indicating a potential oversold condition. However, the forward P/E ratio is extremely high at 178.57, suggesting that the stock may be overvalued relative to its earnings potential. Positive catalysts include a 28.5% increase in customer base and a significant earnings surprise of 1633.33% in Q2, but the stock has seen a 4.18% decline over the past five days, indicating market caution. The main risk is the high forward P/E ratio, which could lead to volatility if earnings do not meet expectations.

Valuation Metrics

The current forward P/E ratio for agilon health, inc. (AGL) is 178.57, compared to its 5-year average forward P/E of 17.99.

Forward P/E

Fair
5Y Average P/E
17.99
Current P/E
178.57
Overvalued
311.67
Undervalued
-275.68

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
134.50
Current EV/EBITDA
13.80
Overvalued
587.03
Undervalued
-318.03

Forward P/S

Fair
5Y Average P/S
1.29
Current P/S
0.25
Overvalued
2.68
Undervalued
-0.09

Alphio AI Price Scenarios for AGL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AGL

$3.37

Scenario price

B

Base

Base · 50%AGL

$3.18

Scenario price

B

Bear

Bear · 25%AGL

$2.51

Scenario price

Whales holding AGL

R

Rock Springs Capital Management LP

+ HoldingAGL

+18.51%

3M Return

I

IOOF Investment Management Limited

+ HoldingAGL

+10.15%

3M Return

D

Durable Capital Partners, LP

+ HoldingAGL

+1.98%

3M Return

Events Timeline

2026-08-05 (ET)

17:00:00

Sees Q3 Adjusted EBITDA at -$5M

17:00:00

agilon health Q2 Revenue $1.49B, Exceeds Expectations

2026-07-23 (ET)

17:00:00

Stocks Decline Amid Deteriorating Macroeconomic Conditions

12:30:00

Major Averages Drop Sharply Amid AI Spending Concerns

2026-07-10 (ET)

09:00:00

agilon health Achieves $229M Savings in 2024

News

AGL FAQ — answered by Alphio AI

agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Agilon Health Inc is currently a hold. The stock is priced at $92.54, with a recent RSI of 42.18 indicating a potential oversold condition. However, the forward P/E ratio is extremely high at 178.57, suggesting that the stock may be overvalued relative to its earnings potential. Positive catalysts include a 28.5% increase in customer base and a significant earnings surprise of 1633.33% in Q2, but the stock has seen a 4.18% decline over the past five days, indicating market caution. The main risk is the high forward P/E ratio, which could lead to volatility if earnings do not meet expectations.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始